1Oliver Adam,Hans-Ruprecht Neuberger,Michael Bohm,et al.Prevention of Atrial Fibrillation With 3-Hvdroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors.Circulation,2008,118(12):1285-1293.
2Young-Xu Y,Jabbour S,Goldberg R,et al.Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.Am J Cardiol,2003,92(12):1379-1383.
3Hanna IR,Heeke B,Bush H,et al.Lipid-lowering drug use is associated with reduced prevalence of atria1 fibrillation in patients with left ventricular systolic dysfunction.Heart Rhythm,2006,3(8):881-886.
4Adabag AS.Nelson DB,Bloomfield HE.Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure.Am Heart J,2007,154(6):1140-1145.
5Dotani MI,Elnicki DM,Jain AC,et al.Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.Am J Cardiol,2000,86(10):1128 -1130,A6.
6Ozaydin M,Dogan A,Varol E,et al.Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation.Cardiology,2007,107(2):117-121.
7Arribas-Leal JM,Pascual-Figal DA,Tomel-Osorio PL,et al.Epidemiology and new predictors of atrial fibrillation after coronary surgery.Rev Esp Cardiol,2007,60(8):841-847.
8Patti G,Chello M.Candura D,et al.Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery:results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.Circulation,2006,114(14):1455-1461.
9Virani SS,Nambi V,Razavi M,et al.Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.Am Heart J,2008,155(3):541-546.
10Siu CW,Lau CP,Tse HF.Prevention of atria1 fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion.Am J Cardiol,2003,92(11):1343-1345.
4Moher D, Schulz KF, Altman D. CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallelgroup randomized trials, JAMA, 2001, 285(15): 1987-1991.
5Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996, 17(1): 1-12.
6Tveit A, Grundtvig M, Gundersen T, et al. Analysis of pravastatin to prevent recurrence of atrial fibrillation After electrical cardioversion. Am J Cardiol, 2004, 93(6): 780-782.
7Dernellis J, Panaretou M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J, 2005, 150(5): 1064.
8Ozaydin M, Varol E, Asian SM, et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation After electrical cardioversion. Am J Cardiol, 2006, 97(10): 1490-1493.
9Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation, 2006, 114(14): 1455-1461.
10Lijnen P, Celis H, Fagard R, et al. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems.J Hypertens, 1994, 12(1): 59-64.
7Hideko N, Koiekiro K, Hidenori U.Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibr!llation[J].Circulation, 2004,101 (22) : 2612.
8Chung MK, Martin DO ,Spreeher D,et al.C-reactive protein eleva- tionin patients with atrial arrhythnfias :inflammatory mechanisms and persistence of atrial fibrillation[J].Circulation, 2001,104(24) : 2886.
9Aviles RJ,Martin DO,Appenson-Hansen C,et al.Inflammation as risk for atrial fibrillation[J].Circulation,2003,108(24):3006.
10Kumagai K,Nakashima H ,Saku K.The HMG-CoA reduetase inhibitor atorvastatin pre- vents atrial fibrillation by inhibiting inflammarion- in a canine sterile pericarditis model[J].Cadiovasc Res, 2004,62(1): 105.
